These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 155067)

  • 1. Covalent modification of human alpha-thrombin with pyridoxal 5'-phosphate. Effect of phosphopyridoxylation on the interaction of thrombin with heparin.
    Griffith MJ
    J Biol Chem; 1979 May; 254(9):3401-6. PubMed ID: 155067
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-function relations in platelet-thrombin reactions. Inhibition of platelet-thrombin interactions by lysine modification.
    White GC; Lundblad RL; Griffith MJ
    J Biol Chem; 1981 Feb; 256(4):1763-6. PubMed ID: 6780552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for essential lysines in heparin cofactor II.
    Church FC; Griffith MJ
    Biochem Biophys Res Commun; 1984 Nov; 124(3):745-51. PubMed ID: 6439196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of phosphopyridoxylation on thrombin interaction with platelet glycoprotein Ib.
    Ternisien C; Jandrot-Perrus M; Huisse MG; Guillin MC
    Blood Coagul Fibrinolysis; 1991 Aug; 2(4):521-8. PubMed ID: 1768765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin interaction with platelet GpIB: role of the heparin binding domain.
    De Candia E; De Cristofaro R; De Marco L; Mazzucato M; Picozzi M; Landolfi R
    Thromb Haemost; 1997 Apr; 77(4):735-40. PubMed ID: 9134652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation of human alpha-thrombin by the myeloperoxidase-H2O2-chloride system: structural and functional effects.
    De Cristofaro R; Landolfi R
    Thromb Haemost; 2000 Feb; 83(2):253-61. PubMed ID: 10739383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrophobic affinity chromatography of human thrombin.
    Lundblad RL; Tsai J; Wu HF; Jenzano JW; White GC; Connolly TM
    Arch Biochem Biophys; 1993 Apr; 302(1):109-12. PubMed ID: 8470887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of heparin or dermatan sulfate to thrombin is essential for the sulfated polysaccharide-accelerated inhibition of thrombin by heparin cofactor II.
    Yamagishi R; Koide T; Sakuragawa N
    FEBS Lett; 1987 Dec; 225(1-2):109-12. PubMed ID: 3691797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of heparin with human alpha-thrombin: effect on the hydrolysis of anilide tripeptide substrates.
    Griffith MJ; Kingdon HS; Lundblad RL
    Arch Biochem Biophys; 1979 Jul; 195(2):378-84. PubMed ID: 475396
    [No Abstract]   [Full Text] [Related]  

  • 10. The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans.
    Van Deerlin VM; Tollefsen DM
    J Biol Chem; 1991 Oct; 266(30):20223-31. PubMed ID: 1939083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of inhibition of thrombin-induced platelet aggregation by pyridoxal phosphate.
    Kornecki E; Feinberg H
    Biochem Biophys Res Commun; 1979 Oct; 90(3):963-8. PubMed ID: 508356
    [No Abstract]   [Full Text] [Related]  

  • 12. Heparin promotes proteolytic inactivation by thrombin of a reactive site mutant (L444R) of recombinant heparin cofactor II.
    Ciaccia AV; Willemze AJ; Church FC
    J Biol Chem; 1997 Jan; 272(2):888-93. PubMed ID: 8995378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin enhances the catalytic activity of des-ETW-thrombin.
    Goodwin CA; Deadman JJ; Le Bonniec BF; Elgendy S; Kakkar VV; Scully MF
    Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):77-83. PubMed ID: 8670135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of heparin cofactor II activity by glycosaminoglycans and adhesive glycoproteins.
    Petzelbauer E; Seiffert D; Beckmann R; Pusch B; Geiger M; Binder BR
    Thromb Res; 1992 Jun; 66(5):559-67. PubMed ID: 1381850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a lysyl residue in antithrombin which is essential for heparin binding.
    Peterson CB; Noyes CM; Pecon JM; Church FC; Blackburn MN
    J Biol Chem; 1987 Jun; 262(17):8061-5. PubMed ID: 3110143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the early stages of the thrombin generation reaction by various glycosaminoglycans.
    Visser A; Meuleman DG
    Thromb Res; 1990 Jun; 58(5):469-79. PubMed ID: 2164263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The preferred pathway of glycosaminoglycan-accelerated inactivation of thrombin by heparin cofactor II.
    Verhamme IM; Bock PE; Jackson CM
    J Biol Chem; 2004 Mar; 279(11):9785-95. PubMed ID: 14701814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pyridoxal-5'-phosphate on aggregation of platelets from stored human concentrates induced by arachidonic acid.
    Nolan ML; Harrington MG; Eljamil A
    Biochem Soc Trans; 1996 Feb; 24(1):95S. PubMed ID: 8674780
    [No Abstract]   [Full Text] [Related]  

  • 19. Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin.
    Chuang YJ; Swanson R; Raja SM; Olson ST
    J Biol Chem; 2001 May; 276(18):14961-71. PubMed ID: 11278930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin neutralization during collection and processing of blood inhibited by pyridoxal 5'-phosphate.
    van Putten J; van de Ruit M; Beunis M; Hemker HC
    Haemostasis; 1984; 14(3):253-61. PubMed ID: 6469101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.